Ok, and I basically share your thoughts...anyway they need to do something more aggressive to cover the cost of NDA filing ( more than 1mln usd if they are allowed for the special procedure...otherwise much more).
And going back to Focalin, I think that something happened with PAR, because almost 1 year it's gone, and absoluting nothing happended (maybe PAR is voluntarily stalling)
Let's hope for some surprise (not Keppra like)